Ulcerative Colitis Studies

You or someone you know may be eligible to take part if:

  • You are between 18 and 75 years of age

  • Have been diagnosed with ulcerative colitis for at least three months

  • Have prior use of at least one medication that was ineffective, lost effectiveness, or resulted in intolerable side effects (preferred, but not required)

BVL Research has multiple studies currently enrolling in Ulcerative Colitis including:

  • Takeda Vedolizumab-4054

  • Merck 8690-002

  • Sanofi EFC18325

For more information contact us.

Previous

All About Clinical Trials
Next

Crohn’s Disease Studies